ANI Pharmaceuticals Launches Duloxetine Delayed-Release Capsules 20, 30 And 60 Mg, Generic Version Of Reference Listed Drug Cymbalta

Benzinga · 2d ago

ANI Pharmaceuticals, Inc. (ANI or the Company) (NASDAQ:ANIP) today announced the launch of Duloxetine Delayed-Release Capsules 20, 30 and 60 mg. ANI’s Duloxetine Delayed-Release Capsules are the generic version of the reference listed drug (RLD) Cymbalta®.

U.S. annual sales for Duloxetine Delayed-Release Capsules totaled approximately $247 million, based on August 2026 moving annual total (MAT) IQVIA data.